Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Dec 23;24(3):490–497. doi: 10.1158/1055-9965.EPI-14-0853

Table 3.

Summary of temporal trend (β-scale) in CpG site methylation, by genomic location and probe type.1

Nonsex chromosomes
X chromosome
Percent loci with significant trend
Percent loci with significant trend
Location/probe type N Negative trend Positive trend N Negative trend Positive trend
All CpG loci 472665 1.86 1.54 11215 1.84 1.64
Enhancer 101663 1.83 1.79 629 1.75 1.91
Known DMR2 36053 1.91 1.29 1231 1.54 1.62
Location with respect to CpG island:
 CpG Island 145571 1.91 1.31 4272 2.01 1.17
 Shore3 108839 1.93 1.50 2837 1.97 1.55
 Shelf3 45790 1.86 1.70 1138 1.85 1.76
Functional location:
 TSS1500 81267 1.94 1.44 2777 2.02 1.76
 TSS200 60005 1.88 1.38 2441 2.17 1.11
 5′UTR 62975 1.88 1.42 2401 2.25 1.71
 1st Exon 37656 1.93 1.34 1635 2.32 1.59
 Body 172068 1.86 1.58 2893 1.69 1.56
 3′UTR 19174 1.83 1.60 513 1.95 3.31
Location by probe type:
Infinium I 132039 1.55 1.59 3042 1.94 1.15
Infinium II 340626 1.99 1.52 8173 1.80 1.82
1

All estimates are adjusted for cell-type composition. Δβ is estimated as twice the between-person standard error (β-scale).

2

DMR: differentially methylated region; TSS: transcription start site; UTR: untranslated region.

3

Shores: up to 2 kb from CpG islands; shelves: from 2 to 4 kb from CpG islands.